Figure 2 | Scientific Reports

Figure 2

From: Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis

Figure 2

Renal and hepatic function tests: bar graph representation of (A) serum urea (SUrea, mg/dL), (B) creatinine (SCreat, mg/dL), (C) alkaline phosphatase (ALP, IU/L), (D) alanine transaminase (ALT, IU/L), (E) total protein (SProt, g/dL), and (F) albumin (SAlb, g/dL), concentrations in the groups: NS diet control, control, NAME, LOS, MMF, TAM and LOS + MMF + TAM. Results are presented as mean ± SEM. *p < 0.05 vs. Control, #: p < 0.05 vs. NAME, †: p < 0.05 vs. LOS, §: p < 0.05 vs. MMF, &: p < 0.05 vs. TAM.

Back to article page